Albertini, R. A., Nicolas, J. C., Actis Dato, V., Ferrer, D. G., Tinti, M. E., Capra, R. H., Chiabrando, G. A. (2022). Decreased low-density lipoprotein receptor-related protein 1 expression in pro-inflammatory monocytes is associated with subclinical atherosclerosis. [Brief Research Report]. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.949778.

Al-Kuraishy, H. M., Hussien, N. R., Al-Naimi, M. S., Al-Gareeb, A. I., & Lugnier, C. (2021). Statins therapy improves acute ischemic stroke in patients with cardio-metabolic disorders measured by lipoprotein-associated phospholipase A2 (Lp-PLA2): New Focal Point. Neurology India, 69(6), 1637–1644. https://doi.org/10.4103/0028-3886.333482

Article  PubMed  Google Scholar 

Al-Kuraishy, H. M., Al-Gareeb, A. I., Elekhnawy, E., & Batiha, G. E. (2024). Possible role of LCZ696 in atherosclerosis: New inroads and perspective. Molecular and Cellular Biochemistry, 479(8), 1895–1908. https://doi.org/10.1007/s11010-023-04816-x

Article  CAS  PubMed  Google Scholar 

Alomair, B. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alshammari, M. A., Alexiou, A., Papadakis, M., et al. (2024). Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism. Thyroid Research, 17(1), 13. https://doi.org/10.1186/s13044-024-00199-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alsaidan, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A., Papadakis, M., Alsayed, K. A., et al. (2023). The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread. Immunity, Inflammation and Disease, 11(3), e798. https://doi.org/10.1002/iid3.798

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alshehri, A. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Jawad, S. F., Khawagi, W. Y., Alexiou, A., et al. (2024). The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis. Journal of Inflammation (London), 21(1), 19. https://doi.org/10.1186/s12950-024-00394-x

Article  CAS  Google Scholar 

Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011). Review: Sporadic cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology, 37(1), 75–93. https://doi.org/10.1111/j.1365-2990.2010.01137.x

Article  CAS  PubMed  Google Scholar 

Austin, S. A., & Combs, C. K. (2010). Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice. Neurobiology of Aging, 31(11), 1854–1866. https://doi.org/10.1016/j.neurobiolaging.2008.10.013

Article  CAS  PubMed  Google Scholar 

Austin, S. A., Sens, M. A., & Combs, C. K. (2009). Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells. Journal of Neuroscience, 29(46), 14451–14462. https://doi.org/10.1523/JNEUROSCI.3107-09.2009

Article  CAS  PubMed  Google Scholar 

Barnes, D. E., & Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurology, 10(9), 819–828. https://doi.org/10.1016/S1474-4422(11)70072-2

Article  PubMed  PubMed Central  Google Scholar 

Basheer, N., Smolek, T., Hassan, I., Liu, F., Iqbal, K., Zilka, N., et al. (2023). Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials. Molecular Psychiatry, 28(6), 2197–2214. https://doi.org/10.1038/s41380-023-02113-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beeri, M. S., Rapp, M., Silverman, J. M., Schmeidler, J., Grossman, H. T., Fallon, J. T., et al. (2006). Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology, 66(9), 1399–1404. https://doi.org/10.1212/01.wnl.0000210447.19748.0b

Article  CAS  PubMed  Google Scholar 

Bennett, S. A., Pappas, B. A., Stevens, W. D., Davidson, C. M., Fortin, T., & Chen, J. (2000). Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiology of Aging, 21(2), 207–214. https://doi.org/10.1016/s0197-4580(00)00131-7

Article  CAS  PubMed  Google Scholar 

Borroni, B., Akkawi, N., Martini, G., Colciaghi, F., Prometti, P., Rozzini, L., et al. (2002). Microvascular damage and platelet abnormalities in early Alzheimer’s disease. Journal of the Neurological Sciences, 203–204, 189–193. https://doi.org/10.1016/s0022-510x(02)00289-7

Article  PubMed  Google Scholar 

Bu, G., Cam, J., & Zerbinatti, C. (2006). LRP in amyloid-beta production and metabolism. Annals of the New York Academy of Sciences, 1086, 35–53. https://doi.org/10.1196/annals.1377.005

Article  CAS  PubMed  Google Scholar 

Carbone, M. G., Pagni, G., Tagliarini, C., Imbimbo, B. P., & Pomara, N. (2021). Can platelet activation result in increased plasma Aβ levels and contribute to the pathogenesis of Alzheimer’s disease? Ageing Research Reviews, 71, 101420. https://doi.org/10.1016/j.arr.2021.101420

Article  CAS  PubMed  Google Scholar 

Chen, R., Zhang, X., Gu, L., Zhu, H., Zhong, Y., Ye, Y., et al. (2021). New insight into neutrophils: A potential therapeutic target for cerebral ischemia. Frontiers in Immunology, 12, 692061. https://doi.org/10.3389/fimmu.2021.692061

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, J., Su, Y., Pi, S., Hu, B., & Mao, L. (2023). Corrigendum: The dual role of low-density lipoprotein receptor-related protein 1 in atherosclerosis. Frontiers in Cardiovascular Medicine 10, 1179643. https://doi.org/10.3389/fcvm.2023.1179643

Article  PubMed  PubMed Central  Google Scholar 

Chen, C., Anqi, W., Ling, G., Shan, W., Liangjun, D., Suhang, S., et al. (2024). Atherosclerosis is associated with plasma Aβ levels in non-hypertension patients. BMC Neurology, 24(1), 218. https://doi.org/10.1186/s12883-024-03722-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clarke, J. R., Lyra, E. S. N. M., Figueiredo, C. P., Frozza, R. L., Ledo, J. H., Beckman, D., et al. (2015). Alzheimer-associated Abeta oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Molecular Medicine, 7(2), 190–210. https://doi.org/10.15252/emmm.201404183.

Dar, N. J., & Glazner, G. W. (2020). Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPalpha). Cellular and Molecular Life Sciences, 77(12), 2315–2330. https://doi.org/10.1007/s00018-019-03404-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

de la Torre, J. C. (2012). Cerebral hemodynamics and vascular risk factors: Setting the stage for Alzheimer’s disease. Journal of Alzheimer’s Disease, 32(3), 553–567. https://doi.org/10.3233/JAD-2012-120793

Article  PubMed  Google Scholar 

Deane, R., Bell, R. D., Sagare, A., & Zlokovic, B. V. (2009). Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease. CNS & Neurological Disorders: Drug Targets, 8(1), 16–30. https://doi.org/10.2174/187152709787601867

Article  CAS  Google Scholar 

Delaby, C., Gabelle, A., Blum, D., Schraen-Maschke, S., Moulinier, A., Boulanghien, J., et al. (2015). Central nervous system and peripheral inflammatory processes in alzheimer’s disease: Biomarker profiling approach. Frontiers in Neurology, 6, 181. https://doi.org/10.3389/fneur.2015.00181

Article  PubMed  PubMed Central  Google Scholar 

Delialis, D., Georgiopoulos, G., Tual-Chalot, S., Angelidakis, L., Aivalioti, E., Mavraganis, G., et al. (2024). Amyloid beta is associated with carotid wall echolucency and atherosclerotic plaque composition. Scientific Reports, 14(1), 14944. https://doi.org/10.1038/s41598-024-64906-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dolan, H., Crain, B., Troncoso, J., Resnick, S. M., Zonderman, A. B., & Obrien, R. J. (2010). Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Annals of Neurology, 68(2), 231–240. https://doi.org/10.1002/ana.22055

Article  PubMed  PubMed Central  Google Scholar 

ElAli, A., Doeppner, T. R., Zechariah, A., & Hermann, D. M. (2011). Increased blood-brain barrier permeability and brain edema after focal cerebral ischemia induced by hyperlipidemia: Role of lipid peroxidation and calpain-1/2, matrix metalloproteinase-2/9, and RhoA overactivation. Stroke, 42(11), 3238–3244. https://doi.org/10.1161/STROKEAHA.111.615559

Article  CAS  PubMed  Google Scholar 

Fani, L., van der Willik, K. D., Bos, D., Leening, M. J. G., Koudstaal, P. J., Rizopoulos, D., et al. (2020). The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study. PLoS Medicine, 17(5), e1003115. https://doi.org/10.1371/journal.pmed.1003115

Article